NYSE:STE - Steris Stock Price, Forecast & News

Steris' stock was trading at $145.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, STE stock has decreased by 10.7% and is now trading at $129.74. View which stocks have been mosted impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Steris.

Steris is scheduled to release its next quarterly earnings announcement on Monday, May 11th 2020. View our earnings forecast for Steris.

Steris PLC (NYSE:STE) posted its quarterly earnings results on Monday, February, 10th. The medical equipment provider reported $1.45 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.42 by $0.03. The medical equipment provider earned $774.30 million during the quarter, compared to analyst estimates of $748.45 million. Steris had a net margin of 13.21% and a return on equity of 16.33%. The firm's revenue for the quarter was up 11.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.26 earnings per share. View Steris' earnings history.

Steris declared a quarterly dividend on Monday, February 10th. Shareholders of record on Tuesday, February 25th will be given a dividend of $0.37 per share on Thursday, March 26th. This represents a $1.48 annualized dividend and a yield of 1.14%. The ex-dividend date is Monday, February 24th. View Steris' dividend history.

Steris updated its FY 2020 After-Hours earnings guidance on Monday, February, 10th. The company provided EPS guidance of 5.65-5.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.57.

4 brokers have issued 1-year price targets for Steris' stock. Their forecasts range from $138.00 to $150.00. On average, they anticipate Steris' stock price to reach $144.33 in the next year. This suggests a possible upside of 11.2% from the stock's current price. View analysts' price targets for Steris.

News coverage about STE stock has been trending very negative recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Steris earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutSteris.

Steris saw a decrease in short interest in March. As of March 13th, there was short interest totaling 1,275,100 shares, a decrease of 18.8% from the February 27th total of 1,570,000 shares. Based on an average daily trading volume, of 881,000 shares, the short-interest ratio is presently 1.4 days. Approximately 1.5% of the shares of the company are sold short. View Steris' Current Options Chain.

Some companies that are related to Steris include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Insulet (PODD), Varian Medical Systems (VAR) and Masimo (MASI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Mastercard (MA), AbbVie (ABBV), Mcdonald's (MCD), Gilead Sciences (GILD), Allergan (AGN), Pfizer (PFE), Stryker (SYK), AT&T (T) and Zimmer Biomet (ZBH).

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Steris' stock is owned by a number of institutional and retail investors. Top institutional investors include Janus Henderson Group PLC (6.38%), State Street Corp (4.23%), WCM Investment Management LLC (2.76%), Massachusetts Financial Services Co. MA (2.30%), Geode Capital Management LLC (1.64%) and William Blair Investment Management LLC (1.26%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View institutional ownership trends for Steris.

STE stock was sold by a variety of institutional investors in the last quarter, including Great West Life Assurance Co. Can, Janus Henderson Group PLC, Principal Financial Group Inc., WCM Investment Management LLC, Bank of New York Mellon Corp, Macquarie Group Ltd., Macquarie Group Ltd., and Renaissance Technologies LLC. Company insiders that have sold Steris company stock in the last year include Cary L Majors, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, and Walter M Rosebrough Jr. View insider buying and selling activity for Steris.

STE stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, Pictet Asset Management Ltd., State Street Corp, Goldman Sachs Group Inc., Geode Capital Management LLC, Massachusetts Financial Services Co. MA, Franklin Resources Inc., and Franklin Resources Inc.. View insider buying and selling activity for Steris.

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of STE stock can currently be purchased for approximately $129.74.

Steris has a market capitalization of $11.00 billion and generates $2.78 billion in revenue each year. The medical equipment provider earns $304.05 million in net income (profit) each year or $4.89 on an earnings per share basis. Steris employs 12,000 workers across the globe. View additional information about Steris.

The official website for Steris is http://www.steris.com/.

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]